Moody National Bank Trust Division Gilead Sciences, Inc. Transaction History
Moody National Bank Trust Division
- $922 Million
- Q3 2024
A detailed history of Moody National Bank Trust Division transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moody National Bank Trust Division holds 16,352 shares of GILD stock, worth $1.44 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
16,352
Previous 13,605
20.19%
Holding current value
$1.44 Million
Previous $933,000
46.84%
% of portfolio
0.15%
Previous 0.07%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
1,893Shares Held
1.02BCall Options Held
12MPut Options Held
9.04M-
Black Rock Inc. New York, NY121MShares$10.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.72 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.32 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.23 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...